Media and Investors Resources
Press Release, 11 February 2019
Kuros Biosciences signs agreement to supply SeaSpine with bone graft incorporating Kuros's advanced submicron surface technology
Press Release, 17 December 2018
Kuros ends transformational year with first MagnetOs sales, lead clinical program on track, and successful capital raise
Press Release, 13 December 2018
Kuros announces final result of capital increase – total gross proceeds of 16.1 million raised
Press Release, 12 December 2018
Kuros announces results of rights offering – capital increase will be implemented
Press Release, 10 December 2018
Kuros receives FDA 510(k) clearance for extending commercial indications of MagnetOs Putty in the United States
Press Release, 06 December 2018
Kuros reports publication of MagnetOs data demonstrating equivalence to autologous bone in spinal fusion